[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345881-105":59,"doc-detail-345881-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epigenetics-and-dna-base-substitutions-of-epsteinbarr-virus-ebv-related-gastric-cancers-implications-for-targeted-therapies","Epigenetics and DNA Base Substitutions of Epstein–Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies","","Gastric adenocarcinomas form a histologically and genomically heterogeneous group of cancers. Using TCGA gastric cohorts, EBV-associated tumors were analyzed to define distinctive mutational and mRNA expression patterns that separate them from other gastric subtypes. The study identifies frequent alterations involving PIK3CA, ARID1A, and BCOR, with a signature of T>G transversions linked to POLH up-regulation, suggesting epigenetic and pathway-dependent therapeutic vulnerabilities.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epigenetics-and-dna-base-substitutions-of-epsteinbarr-virus-ebv-related-gastric-cancers-implications-for-targeted-therapies/345881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epigenetics-and-dna-base-substitutions-of-epsteinbarr-virus-ebv-related-gastric-cancers-implications-for-targeted-therapies/345881.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What distinguishes Epstein–Barr virus (EBV)-related gastric cancers from other gastric cancer subtypes?","Question",{"text":113,"@type":114},"EBV-associated cancers form a distinct subset in TCGA-defined genomic groups, showing characteristic mutational patterns and a specific molecular context compared with other gastric subtypes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which mutations or molecular changes are commonly observed in EBV-related gastric cancers?",{"text":118,"@type":114},"Mutations in PIK3CA are frequent (reported as occurring in 80% of EBV-associated cancers), along with common alterations in epigenetic modifiers such as ARID1A and BCOR. Additional cases may show ERBB2 or PI3K regulatory-unit alterations.",{"name":120,"@type":111,"acceptedAnswer":121},"What DNA base substitution pattern is reported, and how may it be explained?",{"text":122,"@type":114},"EBV-associated cancers do not show excess C>T transitions but do show an increased rate of T>G transversions. Up-regulation of translesion polymerase eta (POLH), which is associated with a T>G signature, is proposed as a contributing factor.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345881,1790145602,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Article  \nEpigenetics and DNA Base Substitutions of Epstein–Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies  \nIoannis A. Voutsadakis 1,2  \nAcademic Editors: Victor Jin and Shengtong Han  \nReceived: 24 May 2026  \nRevised: 26 June 2026  \nAccepted: 27 June 2026  \nPublished: 30 June 2026  \nCopyright: © 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA 52240, USA; ivoutsadakis@yahoo.com or [ivoutsadakis@nosm.ca](ivoutsadakis@nosm.ca)  \n2 Section of Internal Medicine, Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada  \nAbstract  \nBackground: Gastric adenocarcinomas constitute a histologically and genomically heterogeneous group of cancers. The genomic classification of gastric cancers in four groups by The Cancer Genome Atlas (TCGA) has defined a framework for pathogenic discoveries. One of the groups is associated with infection by the gamma herpes virus Epstein–Barr virus (EBV) and represents a distinct subset of gastric cancers with potential therapeutic opportunities. Methods: The EBV-associated cancers from the TCGA gastric cancer cohort were analyzed to determine specific mutational and mRNA expression profiles that set these cancers apart from other gastric cancer subtypes. The cBioportal for Cancer Genomics site was used for downloading and analyzing the primary data. Results: EBV-associated cancers represented about 7% of the cohort. Mutations in the catalytic alpha subunit of PI3K kinase, PIK3CA, and the epigenetic modifiers ARID1A and BCOR were common. PIK3CA mutations were observed in 80% of EBV-associated cancers and frequently affected the hotspot codons E542 and E545 . The few cases without PIK3CA mutations displayed frequent alterations in ERBB2 or in the regulatory unit of PI3K. EBV-associated cancers did not display excess cytidine to thymine (C>T) transitions compared with other gastric cancer genomic subtypes, as would be expected from the high genome methylation caused by the virus. In contrast, an increased rate of T to G (T>G) transversions was observed in EBV-associated cancers. Translesion polymerase eta (POLH), which produces a signature characterized by a preponderance of T>G, was up-regulated in EBV-associated gastric cancers and may be a contributing factor in this increase, up-regulated by wild-type p53 and over-expression of transcription factor IRF1 . Conclusions: The data presented here suggest that mutagenesis in the EBV-associated gastric cancers is not a direct consequence of the virus-derived hypermethylation. Up-regulation of kinase PI3K and its pathway is a prerequisite for EBV transformation, and epigenetic alterations are frequently present, suggesting therapeutic avenues.  \nKeywords: stomach adenocarcinoma; viral; gamma herpesvirus; latency; methylation  \n1. Introduction  \nGastric cancer remains a lethal neoplasm with high prevalence globally [1] . The landmark studies of The Cancer Genome Atlas (TCGA) identified four genomic subtypes of gastric adenocarcinomas: the chromosomal instability (CIN) subtype, which accounts for approximately 50% of cases, and three less prevalent subtypes, namely microsatellite  \ninstability (MSI)-high (16%), genomically stable (13%), and Epstein–Barr virus (EBV)-related (7%) tumors [2] . The four genomic subtypes present specific molecular and clinical features. The predominant CIN-high gastric cancers are characterized, as implied by their name, by a high burden of copy-number alterations, including amplifications of receptor tyrosine kinases and cell-cycle regulators. Frequent mutations in TP53 are also present, supporting the role of p53 function in protecting from large-scale genomic gainsand losses [3] . The MSI-high","cbCaihOI69WdhMZt","https://ap.wps.com/l/cbCaihOI69WdhMZt","pdf",3031759,"English","# Abstract\n# Introduction","[{\"question\":\"What distinguishes Epstein–Barr virus (EBV)-related gastric cancers from other gastric cancer subtypes?\",\"answer\":\"EBV-associated cancers form a distinct subset in TCGA-defined genomic groups, showing characteristic mutational patterns and a specific molecular context compared with other gastric subtypes.\"},{\"question\":\"Which mutations or molecular changes are commonly observed in EBV-related gastric cancers?\",\"answer\":\"Mutations in PIK3CA are frequent (reported as occurring in 80% of EBV-associated cancers), along with common alterations in epigenetic modifiers such as ARID1A and BCOR. Additional cases may show ERBB2 or PI3K regulatory-unit alterations.\"},{\"question\":\"What DNA base substitution pattern is reported, and how may it be explained?\",\"answer\":\"EBV-associated cancers do not show excess C\\u003eT transitions but do show an increased rate of T\\u003eG transversions. Up-regulation of translesion polymerase eta (POLH), which is associated with a T\\u003eG signature, is proposed as a contributing factor.\"}]","Epigenetics and DNA Base Substitutions of Epstein–Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies | PDF",1790059224,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/986e4a4325dbbc53c71688596ea9796b.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bec1410405fe6c50e6ba2ab8d589e50.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee8b3d0ba599198d62ae460fa5067a73.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5f779122f791909db8e6d318c5cd9dd.webp",980,1385]